Varithena ®  is a polidocanol injectable microfoam used for the treatment of vein disease and varicose veins. Varithena ® a is the only FDA-approved foam treatment used to treat varicose veins caused by problems with the GSV (Great Saphenous Vein) and other related veins in the leg’s GSV system. Certain risk factors such as family history, aging, pregnancy, being overweight, or prolonged standing as a part of your job make Varithena ®  a faster, and less painful, option for treatment of vein disease. Varithena ® is not thermal ablation and does not require multiple injections to numb the treatment site as with tumescent anesthesia. The administration of Varithena ®  is minimally invasive: There are no incisions, sedation, or general anesthesia required. Some activities can be resumed the very same day, but heavy exercise should be avoided for at least one week. Screen Shot 2017-02-02 at 2.18.41 PM

Here’s how the procedure is done:

Using one single injection, your physician will administer a small amount of Varithena ® into the malfunctioning vein. The Varithena ®  microfoam fills and treats the desired section of the vein, collapsing the diseased vein. Once the vein has collapsed, blood flow will naturally shift to healthier veins nearby.

What results can be expected?

After treatment, you can expect to feel the effects of Varithena ®  as an improvement in symptoms including heaviness, achiness, swelling, throbbing, and itching. Also, the majority of patients experienced improved vein appearance in assessments by both patients and doctors.

Click here to view common questions about treatment with Varithena ®.